Colleagues, Biologics are changing the way we treat not only cancers but also a wide range of diseases including rheumatoid arthritis, lupus, psoriasis, inflammatory bowel disease, asthma, multiple sclerosis, and dementia. Many of these agents are administered by intravenous infusion. In the past, our patients had to be referred to an outside infusion center to receive treatment. We are delighted to announce that officially starting February 1st, patients can receive infusions of biologics at the Infusion Services suite on the 4th floor of the MARC. The Infusion Service is a joint initiative between UTHP and ALTUS, a third party infusion vendor, and will provide patients and their providers with convenient scheduling and ordering through EPIC. This opening is the result of many months of hard work by the Department of Medicine and Division of Rheumatology with the support of UTHP project management, clinical operations, health IT, facility management, revenue and finance teams, and many others. The Infusion Service will begin by providing infusions for Rheumatologic disorders but quickly expand to cover a wide variety of conditions. The Medical Director for the Infusion Service is Dr. Inma Del Rincon, Professor of Medicine/Rheumatology. Dr. Del Rincon will be meeting with provider groups across the campus to educate them about the infusion service and to work collaboratively to expand the scope of services provided. Please, contact Dr. Del Rincon, delrincon@uthscsa.edu, for more information about MARC Infusion Services.